Name
osaühing MirMed
Registry code
11263553
VAT number
EE101079736
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.07.2006 (18)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
40 464 €
6 310 €
16%
-
35 876 €
0
Submitted
No tax arrears
18%
9%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Mirje Kähari 01.01.1957 (67) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 13.02.2020 | 2020 25.05.2021 | 2021 28.03.2022 | 2022 25.01.2023 | 2023 31.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 24 551 € | 35 860 € | 47 565 € | 80 331 € | 40 464 € |
| Net profit (loss) for the period | 7 646 € | 6 700 € | 4 867 € | 1 631 € | 6 310 € |
| Profit Margin | 31% | 19% | 10% | 2% | 16% |
| Current Assets | 36 339 € | 37 215 € | 32 613 € | 19 417 € | 38 616 € |
| Fixed Assets | 804 € | 17 676 € | 14 857 € | 13 619 € | 35 000 € |
| Total Assets | 37 143 € | 54 891 € | 47 470 € | 33 036 € | 73 616 € |
| Current Liabilities | 20 775 € | 31 823 € | 19 535 € | 3 470 € | 37 740 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 16 368 € | 23 068 € | 27 935 € | 29 566 € | 35 876 € |
| Employees | 1 | 1 | 1 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 4 089.17 € | 212.58 € | - | - |
| 2023 Q4 | 30 818.12 € | 1 494.07 € | - | - |
| 2023 Q3 | 3 883.07 € | 394.52 € | - | - |
| 2023 Q2 | 3 427.8 € | - | - | - |
| 2023 Q1 | 2 668.83 € | 251.9 € | - | - |
| 2022 Q4 | 6 689.1 € | 583.46 € | - | - |
| 2022 Q3 | 28 740.5 € | 26.68 € | - | - |
| 2022 Q2 | 28 292.41 € | 420.35 € | - | - |
| 2022 Q1 | 24 785.13 € | 1 370.48 € | 1 114.29 € | - |
| 2021 Q4 | 18 804.88 € | 1 681.01 € | 1 253.58 € | - |
| 2021 Q3 | 9 534.86 € | 1 447.35 € | 1 253.58 € | - |
| 2021 Q2 | 10 889.81 € | 1 930.1 € | 1 253.58 € | - |
| 2021 Q1 | 6 177.83 € | 1 407.22 € | 1 253.58 € | 1 |
| 2020 Q4 | 10 997.86 € | 1 871.92 € | 1 253.58 € | 1 |
| 2020 Q3 | 9 249.13 € | 1 692.35 € | 1 253.58 € | 1 |
| 2020 Q2 | 9 662.67 € | 1 392.04 € | 1 253.58 € | 1 |
| 2020 Q1 | 10 189.92 € | - | 1 253.58 € | 1 |
